Dow Up0.11% Nasdaq Up0.50%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYQ
117.30 0.44(0.38%) Aug 29, 4:02PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2009Dec 31, 2008Dec 31, 2007
Net Income 263,741   (23,714) (6,186)
Operating Activities, Cash Flows Provided By or Used In
Depreciation86,381  66,480  87,968  
Adjustments To Net Income(84,931)1,542  90,822  
Changes In Accounts Receivables(1,508)11,038  31,801  
Changes In Liabilities(41,949)164,276  (22,517)
Changes In Inventories13,193  (22,369)(732)
Changes In Other Operating Activities(2,885)19,276  (88,635)
Total Cash Flow From Operating Activities 183,553   216,529   92,521  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures20,047  (16,575)(32,222)
Investments265,026  45,149  (35,885)
Other Cash flows from Investing Activities327,603  141,344  28,765  
Total Cash Flows From Investing Activities (342,480) 169,918   (39,342)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock242,765  (157,463)(84,269)
Net Borrowings500,700  (329,801)(8,878)
Other Cash Flows from Financing Activities(7,099)12,260  (170)
Total Cash Flows From Financing Activities 29,909   (475,004) (93,317)
Effect Of Exchange Rate Changes(2,484)(21,226)23,924  
Change In Cash and Cash Equivalents (131,502) (109,783) (16,214)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.